Bio Roundup: Lung Cancer Questions, Migraine Races, HIV Battle & More
Xconomy
FEBRUARY 9, 2018
A big domino fell this week: data from a two-drug immunotherapy combination developed by Bristol-Myers Squibb. The top biopharma story of the week involves the fast-moving field of lung cancer, which, as we’ve written previously, has several key trials reading out in 2018. But the results, touted as positive, left more questions than answers.
Let's personalize your content